Clifford Chance represented Morgan Stanley and the lenders, McGuireWoods and Conyers represented Genesis. Genesis has successfully closed a new six-year US$215 million Term Loan. The proceeds...
Genesis’ US$215 Million Term Loan
Escale’s Repurchase of 35% Share Capital from Qualicorp
Madrona Fialho Advogados advised Escale Health Seguros e Corretagem on the deal. Escale Health Seguros e Corretagem, a subsidiary of Escale Tecnologia e Marketing for business...
Celest Therapeutics’ Collaboration with Senti Biosciences
Wilson Sonsini Goodrich & Rosati represented Celest Therapeutics in the transaction. Celest Therapeutics (Shanghai) Co. Ltd (“Celest”) announced a collaboration with Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti...
Glenstone REIT’s Acquisition of Clifford Property Company
Knights advised Glenstone REIT plc., one of the UK’s leading Real Estate Investment Trusts, in its acquisition of the 100-year-old Clifford Property Company. The Clifford portfolio,...
Milkyway International Chemical Supply Chain’s Acquisition of Shares of LHN Logistics Limited
RHTLaw Asia advised Milkyway International Chemical Supply Chain Pte. Ltd. on the deal. Milkyway International Chemical Supply Chain Pte. Ltd., the Singapore subsidiary of Milkyway Chemical...
Linamar’s $64 Million Acquisition of Mobex Propulsion-Agnostic Business
Aird & Berlis LLP represented Linamar on the acquisition. On November 1, 2023, Linamar Corporation (TSX: LNR) announced that it has completed its acquisition of a...
Edify’s R$2,7 Billion Acquisition of EDP Brasil
Mattos Filho Advogados advised Edify, while Madrona Fialho Advogados advised EDP on the deal. Edify Empreendimentos e Participações, an affiliate of Actis Assessoria Investimentos, announced the...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
Basilea Pharmaceutica’s Asset Purchase Agreement With Amplyx Pharmaceuticals
Lenz & Staehelin is advising Pfizer and Amplyx Pharmaceuticals on this transaction. Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into an asset purchase agreement with Amplyx Pharmaceuticals,...
proPellets Austria’s Antitrust Investigation
Schoenherr supported proPellets Austria on the deal. proPellets Austria, an association of the Austrian wood pellet industry, in connection with a dawn raid by the Austrian...
Simmunome’s $2 Million Pre-Seed Funding Round
Osler, Hoskin & Harcourt LLP advised Simmunome on the round. On September 18, 2023, Simmunome announced it secured $2 million in a pre-seed funding round led...
ADDvise’s R$210 Million Acquisition of Kolplast
Madrona Fialho Advogados advised Kolplast Ci, while FM/Derraik advised ADDvise on the deal. Addvise Group Ab (Publ), through ADDvise Brasil Participações, has entered into a share...